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Amplification and sequencing of mycobacterial ribosomal RNA genes (16S rDNA) may per-
mit the detection of growth-deficient species (i.e., those exhibiting no growth or those whose
growth is delayed for more than 12 weeks). Of blood samples from 26 patients with AIDS and a
liver sample from one additional AIDS patient, three samples (two of blood and the one of liver)
were positive by polymerase chain reaction only; cultures of these three samples remained nega-
tive for more than 12 weeks. Analysis of amplified 16S rDNA from blood revealed a sequence
characteristic of Mycobacterium genavense in the first case, in which one of many previous blood
cultures had also been positive for M. genavense. The sequences found in the second and third
cases were characteristic of Mycobacterium avium. The sample from the second patient was a
liver biopsy specimen in which acid-fast bacilli were visualized; the culture of this specimen
yielded M. avium after 7 months. The third sample was a blood sample from a patient in whom a
relapse of treated M. avium infection was suspected. These results indicate that amplification and
sequencing of mycobacterial 16S rDNA may permit early diagnosis and provide a rationale for
treatment of infections due to growth-deficient mycobacteria.
Conventional methods for the detection and identification
of mycobacteria depend on the organisms' growth in culture
and subsequent analysis by hybridization with nucleic acid
probes [1] or by biochemical testing on solid media [2]. New
techniques involve analysis of mycobacterial DNA and may
be very useful in the identification of positive cultures [3]:
with use of oligonucleotides complementary to sequences
common to all mycobacteria, a part of the 16S rRNA gene
(16S rDNA) is amplified by PCR, and species-specific vari-
able regions are analyzed by sequencing [4]. By this ap-
proach, several new mycobacterial species have been de-
tected and identified [5-7]. Such techniques are usually
applied to material derived from cultures; however, growth-
deficient species or isolates from antibiotic-treated patients
may fail to grow in cultures.
We amplified mycobacterial DNA directly from the blood
of 26 patients with AIDS and from a livei biopsy sample of
one additional AIDS patient. Herein we report in detail our
findings for the three patients whose PCR result was positive
but whose culture either was negative or exhibited only de-
layed growth (i.e., growth after >12 weeks).
Methods
Patients with HIV infection and suspected mycobactere-
mia underwent venous blood sampling. The blood sample
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was divided into two 5-mL portions. One portion was di-
rectly cultured on liquid Middlebrook 7H11 medium (Bac-
tec 13A; Becton-Dickinson, Towson, MD). The other was
collected in EDTA tubes, and WBCs were prepared with a
Ficoll gradient (Ficoll-Paque; Pharmacia P-L Biochemicals,
Milwaukee).
For PCR, a 100-4 volume of WBCs was lysed twice with
300 AL of NP40 (0.4%) in water, and DNA was extracted as
described previously [4]. In one case (patient 2; see Results),
a portion of a frozen liver biopsy sample (-3 mm 3) was
minced and extracted; this sample was then subjected to
PCR. In order to control contamination, each step was per-
formed under a specially equipped hood in a separate labora-
tory, and samples from patients were interspersed with nega-
tive control samples.
A 10-AL portion of extracted DNA was used for amplifica-
tion of a 1,039-bp fragment of the mycobacterial 16S rRNA
gene by PCR; one biotinylated primer (285) specific for bac-
terial 16S rRNA and one ,mycobacterial genus-specific
primer (264) were employed [4]. PCR was conducted as de-
scribed previously [4]. Amplification of a fragment of the
correct size was monitored by agarose gel electrophoresis and
ethidium bromide staining. A single-strand sequencing tem-
plate was then purified by binding of the amplified DNA
strand containing the biotinylated primer to streptavidin-
coated magnetic beads (Dynal; Oslo) according to the manu-
facturer's instructions [8]. Manual sequencing of a species-
specific region of the 16S rRNA gene was undertaken by the
Sanger method [9]. Sequenase 2.0 (USB, Cleveland) was
used as recommended by the manufacturer; a bacterium-spe-
cific internal primer (244) was also employed [4].
All samples of blood and the minced liver-biopsy speci-
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Table 1. Comparison of mycobacterial culture and PCR results
for samples from 27 patients with AIDS.
Culture
result












NOTE. Twenty-six blood samples and one liver sample were tested.
men were cultured on liquid Middlebrook 7H 1 1 medium
(Bactec 13A). These cultures were checked twice weekly
during the first 2 weeks and then weekly; after 2 months of
incubation, cultures were monitored at 2-week intervals for
at least 4 months. Mycobacterium avium isolates from liquid
cultures were identified with nucleic acid probes (Accu-
Probe; Gen-Probe, San Diego) in accordance with the manu-
facturer's instructions.
Results
Each of 27 HIV-positive patients with CD4+ lymphocyte
counts of <100/AL provided one sample for examination by
PCR (table 1). All patients were febrile and had lost weight.
Mycobacterial infection was suspected and mycobacterial
culture was attempted in all cases. Cultures yielded M. avium
in nine cases. In two additional instances, cultures showed
limited mycobacterial growth after 6 weeks; the organism
was later identified as Mycobacterium genavense by molecu-
lar techniques [5]. Eight (73%) of the 11 culture-positive pa-
tients also had positive results of PCR, while three were posi-
tive only by culture. Conversely, three patients with positive
PCR results had cultures that remained negative for more
than 12 weeks.
The first of these patients (patient 1), a 28-year-old
woman, was hospitalized in January 1992 with fever, ane-
mia, and weight loss. Her CD4+ lymphocyte count was 20/
AL. Repeated blood cultures were negative with one excep-
tion: in September 1992, mycobacterial DNA with the
sequence of M. genavense was amplified from a single blood
culture bottle showing limited growth (growth index, <400).
Treatment was started but had to be discontinued because of
severe intolerance. In January 1993, blood was collected in
EDTA tubes and subjected to PCR, which revealed a se-
quence characteristic of M. genavense (figure 1). Cultures of
blood collected at that time have remained sterile for 6
months. The patient died in January 1993; no autopsy was
done.
Patient 2 was a 29-year-old HIV-positive injection drug
user who had had Pneumocystis carinii pneumonia in 1990
and who presented in the autumn of 1991 with intermittent
fever, weakness, and weight loss. Her CD4 + lymphocyte
count was 8/4. Bacterial pneumonia and oral candidiasis
were diagnosed and treated, but weight loss and intermittent
fever persisted. In October 1991 and March 1992, several
blood cultures were negative. In May 1992, a liver biopsy
revealed granulomatous hepatitis, with rare acid-fast rods
within macrophages. A portion of this biopsy sample was
processed for mycobacteria by PCR, which revealed a se-
quence characteristic of M. avium (figure 1). The patient re-
ceived clarithromycin, ethambutol, rifampin, and amikacin.
She became afebrile and gained 5 kg. After 7 months, a cul-
ture of her liver biopsy specimen yielded an acid-fast bacte-
rium, which was identified as M. avium by both the 16S
rDNA sequence and nucleic acid probes. Subcultured on
solid medium (Middlebrook 7H11), this isolate took 7 weeks
to attain visible growth.
Patient 3 was a 48-year-old homosexual man who had had
Kaposi's sarcoma since 1988 and who developed P. carinii
pneumonia and cytomegalovirus retinitis in the summer of
1992. His CD4+ lymphocyte count was 4/AL. Blood cultures
were positive for M. avium in September 1992, when the
patient presented with fever, weight loss, and hepatomegaly.
Treatment with amikacin, clofazimine, clarithromycin, and
ethambutol was accompanied by the disappearance of fever
and hepatomegaly. In November 1992, therapy with amika-
cin and clofazimine was discontinued. In January 1993,
while still being treated with clarithromycin and ethambutol,
the patient was hospitalized because of a relapse of fever and
hepatomegaly. Venous blood was collected in EDTA tubes
for PCR, which revealed sequences characteristic of M.
avium (figure 1). Treatment was adjusted, but the patient
died 4 weeks later; no autopsy was conducted. Blood cul-
tures remained negative for more than 6 months.
Discussion
Confirming suspected infection with atypical mycobac-
teria is often an exercise in frustration. Clinical symptoms
and signs are nonspecific, and weeks pass while the results of
culture are awaited. A negative culture result does not settle
the issue because some mycobacteria, such as M. genavense
[5] and Mycobacterium ulcerans [10], do not grow at all on
most media. One study has shown that supplementation with
mycobactin J may promote the growth of M. genavense [11].
However, in our experience, this approach is not always suc-
cessful.
DNA-based diagnosis is undergoing extensive trials, most
often for the detection of Mycobacterium tuberculosis in spu-
tum [12]. Diagnosis based on analyses of blood and tissue,
particularly when atypical mycobacteria are involved, has
been hindered by difficulties with DNA extraction and by
the inhibition of PCR by blood constituents [13]. Therefore,
no standard protocols exist for the routine use of these tech-
niques in laboratories. Even with perfect DNA extraction
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Figure 1. Part of the 16S rRNA gene of various mycobacterial species and clinical strains: positions 179-215 (E. coli alignment). Only
nucleotides different from those of M. tuberculosis are shown. Dashes indicate deletions.
. • ... ..T .AA ..0
5'	 ... ..T .AA ..0
and amplification, PCR is probably not as sensitive as cul-
ture for the detection of growth-proficient mycobacteria: my-
cobacteremia is of variable intensity, with <1 to >5 X 10"
microorganisms/mL [ 1 4]. In our assay, however, the maxi-
mal amount of DNA input into the PCR reaction did not
exceed 2 lig, and thus the inhibition of amplification was
avoided (data not shown). This amount of DNA is extracted
from <250 ps of blood or tissue. There may be no mycobac-
terial DNA in such a sample, while a conventional culture
using 5 mL of blood is still positive [15]. This circumstance
could explain the three PCR-negative but culture-positive
samples (table 1).
In most studies comparing DNA-based techniques with
conventional methods, some samples were DNA-positive
but culture-negative. In cases of suspected tuberculosis, the
proportion was 54 of 271, or 20% [ 1 3]. These samples were
usually from antibiotic-treated patients and from patients
who had M. tuberculosis cultured simultaneously from other
sites. This fact suggests that the PCR results reflected true
infection and not laboratory contamination. In cases of sus-
pected M. avium bacteremia in patients with AIDS, 32 (14%)
of 228 culture-negative specimens tested positive by PCR
[16]. However, since no details were given regarding the ori-
gin of these specimens, it is difficult to judge the clinical
significance of these results. The sensitivity of PCR raises
difficult issues of interpretation that are particularly trouble-
some when DNA from facultative pathogens (such as atypi-
cal mycobacteria) is found in normally unsterile specimens,
such as sputum, urine, feces, and gastric contents. Con-
versely, amplification of mycobacterial genes from normally
sterile specimens such as blood, CSF, or liver biopsy samples
is probably significant.
In the three cases presented in detail herein, the circum-
stances suggest that contamination was unlikely and that the
laboratory findings reflect true infection. In case 1, M. gena-
vense, a mycobacterium that is notoriously difficult to culture
[5, 17], had grown once before in a blood culture. In case 2,
the culture confirmed the PCR result after an extremely long
delay. In case 3, cultures had previously been positive for M.
avium but became negative during treatment; the results of
PCR, but not of culture, became positive when the patient
had a clinical relapse. Thus, as in many other infections,
positive cultures may be more difficult to obtain in mycobac-
teremia if the patient has been treated. The diagnosis of re-
lapse will then depend on amplification and sequencing of
bacterial DNA.
Our report demonstrates that in selected cases the direct
amplification of DNA from blood or biopsy samples may be
the only means of diagnosing infections with growth-defi-
cient mycobacteria. The diagnosis is valuable mainly be-
cause it justifies appropriate treatment of patients with
AIDS, in whom the administration of any additional drug
requires critical evaluation.
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